Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06034990 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ICU Fluid Utilization Survey in Southeast Asia

Study acronym: Fluid-SEA
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description expanded, about 8 words
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 3 words
  2. Primary completion date changed from estimate of Sep 2024 to Jul 31, 2025
    • Study completion date: Sep 2024 to Sep 30, 2026
    • Site details revised
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 2023 to Jan 31, 2024
    • Study sites: 0 to 1
    v3
  4. Eligibility criteria shortened, about 3 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia. The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.
Trial Details
NCT Number NCT06034990
Lead Sponsor Chulalongkorn University
Conditions
(from sponsor)		 Critical Illness
Related terms Critical Illness, Hemorrhage, Sepsis
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov